BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAF8.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $5,000 | +25.0% | 43,000 | 0.0% | 0.00% | – |
| Q3 2019 | $4,000 | -20.0% | 43,000 | 0.0% | 0.00% | – |
| Q2 2019 | $5,000 | +150.0% | 43,000 | -36.8% | 0.00% | – |
| Q1 2019 | $2,000 | -75.0% | 68,000 | 0.0% | 0.00% | – |
| Q4 2018 | $8,000 | -99.9% | 68,000 | 0.0% | 0.00% | -100.0% |
| Q3 2018 | $8,147,000 | +10212.7% | 68,000 | 0.0% | 0.01% | – |
| Q2 2018 | $79,000 | +5.3% | 68,000 | 0.0% | 0.00% | – |
| Q1 2018 | $75,000 | +240.9% | 68,000 | +277.8% | 0.00% | – |
| Q4 2017 | $22,000 | 0.0% | 18,000 | 0.0% | 0.00% | – |
| Q3 2017 | $22,000 | +4.8% | 18,000 | 0.0% | 0.00% | – |
| Q2 2017 | $21,000 | -99.2% | 18,000 | -99.2% | 0.00% | -100.0% |
| Q1 2017 | $2,634,000 | -30.9% | 2,211,000 | -31.1% | 0.00% | -25.0% |
| Q4 2016 | $3,811,000 | -5.1% | 3,211,000 | 0.0% | 0.00% | -20.0% |
| Q3 2016 | $4,014,000 | +9.2% | 3,211,000 | 0.0% | 0.01% | +25.0% |
| Q2 2016 | $3,677,000 | -4.2% | 3,211,000 | 0.0% | 0.00% | -20.0% |
| Q1 2016 | $3,837,000 | -17.4% | 3,211,000 | -6.9% | 0.01% | 0.0% |
| Q4 2015 | $4,646,000 | +0.3% | 3,450,000 | 0.0% | 0.01% | -16.7% |
| Q3 2015 | $4,632,000 | -14.0% | 3,450,000 | 0.0% | 0.01% | 0.0% |
| Q2 2015 | $5,386,000 | +3.5% | 3,450,000 | 0.0% | 0.01% | +20.0% |
| Q1 2015 | $5,205,000 | +3.9% | 3,450,000 | -15.9% | 0.01% | 0.0% |
| Q4 2014 | $5,009,000 | +11.0% | 4,100,000 | 0.0% | 0.01% | 0.0% |
| Q3 2014 | $4,514,000 | +8107.3% | 4,100,000 | -19.6% | 0.01% | – |
| Q2 2014 | $55,000 | -98.6% | 5,100,000 | +41.7% | 0.00% | -100.0% |
| Q1 2014 | $4,002,000 | +42.9% | 3,600,000 | +38.5% | 0.01% | +66.7% |
| Q4 2013 | $2,800,000 | – | 2,600,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|